Primaquine-induced haemolysis in females heterozygous for G6PD deficiency

Primaquine-induced haemolysis in females heterozygous for G6PD deficiency

Oxidative agents can cause acute haemolytic anaemia in persons with G6PD deficiency. Understanding the relationship between G6PD genotype and the phenotypic expression of the enzyme deficiency is necessary so that severe haemolysis can be avoided. The patterns of oxidative haemolysis have been well...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Chu, C, Bancone, G, Nosten, F, White, N, Luzzatto, L
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	BioMed Central 2018

Míreanna comhchosúla

Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
de réir: Cindy S. Chu, et al.
Foilsithe / Cruthaithe: (2018-03-01)

Modelling primaquine-induced haemolysis in G6PD deficiency
de réir: White, N, et al.
Foilsithe / Cruthaithe: (2017)

Modelling primaquine-induced haemolysis in G6PD deficiency
de réir: James Watson, et al.
Foilsithe / Cruthaithe: (2017-02-01)

Primaquine induced haemolysis in G6PD heterozygous females treated for the radical cure of Plasmodium vivax malaria: a nested cohort study
de réir: Chu, C, et al.
Foilsithe / Cruthaithe: (2017)

Haemolysis in G6PD heterozygous females treated with primaquine for Plasmodium vivax malaria: a nested cohort in a trial of radical curative regimens
de réir: Chu, C, et al.
Foilsithe / Cruthaithe: (2017)

Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.
de réir: Cindy S Chu, et al.
Foilsithe / Cruthaithe: (2017-02-01)

The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis
de réir: Chu, C, et al.
Foilsithe / Cruthaithe: (2019)

G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients
de réir: Sara Avalos, et al.
Foilsithe / Cruthaithe: (2018-11-01)

Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects.
de réir: Germana Bancone, et al.
Foilsithe / Cruthaithe: (2016-01-01)

The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis [version 2; peer review: 2 approved]
de réir: Cindy S. Chu, et al.
Foilsithe / Cruthaithe: (2019-04-01)

G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs
de réir: Germana Bancone, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Hemolytic potential of tafenoquine in female volunteers heterozygous for glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PD Mahidol variant) versus G6PD-normal volunteers
de réir: Rueangweerayut, R, et al.
Foilsithe / Cruthaithe: (2017)

G6PD variants and haemolytic sensitivity to primaquine and other drugs
de réir: Bancone, G, et al.
Foilsithe / Cruthaithe: (2021)

Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common.
de réir: White, N, et al.
Foilsithe / Cruthaithe: (2012)

Rationale for recommending a lower dose of primaquine as a <it>Plasmodium falciparum</it> gametocytocide in populations where G6PD deficiency is common
de réir: White Nicholas J, et al.
Foilsithe / Cruthaithe: (2012-12-01)

The reality of using primaquine.
de réir: Burgoine, K, et al.
Foilsithe / Cruthaithe: (2010)

Dengue complicated by acute haemolysis, methaemoglobinemia, hepatitis and rhabdomyolysis in a patient with G6PD deficiency
de réir: R. Arujun, et al.
Foilsithe / Cruthaithe: (2019-12-01)

G6PD deficiency: global distribution, genetic variants and primaquine therapy.
de réir: Howes, R, et al.
Foilsithe / Cruthaithe: (2013)

G6PD Deficiency. Global Distribution, Genetic Variants and Primaquine Therapy
de réir: Howes, R, et al.
Foilsithe / Cruthaithe: (2013)

Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis
de réir: Devine, A, et al.
Foilsithe / Cruthaithe: (2017)

The reality of using primaquine
de réir: Bancone Germana, et al.
Foilsithe / Cruthaithe: (2010-12-01)

Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.
de réir: Angela Devine, et al.
Foilsithe / Cruthaithe: (2017-05-01)

Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria
de réir: Satyagraha, AW, et al.
Foilsithe / Cruthaithe: (2021)

The G6PD flow-cytometric assay is a reliable tool for diagnosis of G6PD deficiency in women and anaemic subjects
de réir: Bancone, G, et al.
Foilsithe / Cruthaithe: (2017)

Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria
de réir: Taylor, WRJ, et al.
Foilsithe / Cruthaithe: (2021)

Unmasking hidden risks: A case of primaquine-induced intravascular hemolysis in G-6-PD deficient malaria patient
de réir: Tanatorn Soravipukuntorn, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.
de réir: Walter R J Taylor, et al.
Foilsithe / Cruthaithe: (2021-09-01)

Characterization of G6PD genotypes and phenotypes on the northwestern
de réir: Bancone, G, et al.
Foilsithe / Cruthaithe: (2014)

X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria.
de réir: Aldiouma Guindo, et al.
Foilsithe / Cruthaithe: (2007-03-01)

Barriers to routine G6PD testing prior to treatment with primaquine.
de réir: Ley, B, et al.
Foilsithe / Cruthaithe: (2017)

Barriers to routine G6PD testing prior to treatment with primaquine
de réir: Benedikt Ley, et al.
Foilsithe / Cruthaithe: (2017-08-01)

Safety of weekly primaquine in G6PD deficient patient with relapsing vivax malaria: A case report
de réir: Deepali Savargaonkar, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
de réir: Rajasekhar, M, et al.
Foilsithe / Cruthaithe: (2023)

Case Series of Primaquine-Induced Haemolytic Events in Controlled Trials with G6PD Screening
de réir: Ayleen Kosasih, et al.
Foilsithe / Cruthaithe: (2023-09-01)

Characterization of G6PD Genotypes and Phenotypes on the Northwestern Thailand-Myanmar Border
de réir: Bancone, G, et al.
Foilsithe / Cruthaithe: (2014)

Performance of the carestart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening
de réir: Kim, S, et al.
Foilsithe / Cruthaithe: (2011)

Cytochemical flow analysis of intracellular G6PD and aggregate analysis of mosaic G6PD expression.
de réir: Kalnoky, M, et al.
Foilsithe / Cruthaithe: (2017)

Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.
de réir: Kim, S, et al.
Foilsithe / Cruthaithe: (2011)

Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers
de réir: Pukrittayakamee, S, et al.
Foilsithe / Cruthaithe: (2024)

Primaquine-induced severe hemolysis in the absence of concomitant malaria: effects on G6PD activity and renal function
de réir: Douglas, NM, et al.
Foilsithe / Cruthaithe: (2022)